393
Views
9
CrossRef citations to date
0
Altmetric
Review Articles

A meta-analysis of preclinical studies using antioxidants for the prevention of cisplatin nephrotoxicity: implications for clinical application

, , , , &
Pages 780-800 | Received 10 Sep 2020, Accepted 11 Oct 2020, Published online: 10 Nov 2020

References

  • Aamir K, Khan HU, Hossain CF, Afrin MR, Shaik I, Salleh N, Giribabu N, Arya A. 2019. Oral toxicity of arjunolic acid on hematological, biochemical and histopathological investigations in female Sprague Dawley rats. PeerJ. 7:e8045.
  • Abdel Moneim AE, Othman MS, Aref AM. 2014. Azadirachta indica attenuates cisplatin-induced nephrotoxicity and oxidative stress. Biomed Res Int. 2014:647131.
  • Abdel-Aziz AM, Abdellah I M, Ali El-Shi A, AbdelTawab N, Geddawy A, Abdelrahma A. 2018. Prophylactic effect of diacerein against cisplatin-induced nephrotoxicity in rats. Int J Pharmacol. 14(3):384–390.
  • Abdel-Daim MM, El-Sayed YS, Eldaim MA, Ibrahim A. 2017. Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats. Naunyn Schmiedebergs Arch Pharmacol. 390(3):301–309.
  • Abdelrahman AM, Al Suleimani Y, Shalaby A, Ashique M, Manoj P, Al-Saadi H, Ali BH. 2019. Effect of levosimendan, a calcium sensitizer, on cisplatin-induced nephrotoxicity in rats. Toxicol Rep. 6:232–238.
  • Abdelrahman AM, Al Suleimani Y, Shalaby A, Ashique M, Manoj P, Nemmar A, Ali BH. 2019. Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice. Naunyn Schmiedebergs Arch Pharmacol. 392(1):45–53.
  • Abdel-Wahab W, Moussa F, Saad N. 2017. Synergistic protective effect of N-acetylcysteine and taurine against cisplatin-induced nephrotoxicity in rats. Drug Des Devel Ther. 11:901–908.
  • Abourashed EA. 2013. Bioavailability of plant-derived antioxidants. Antioxidants. 2(4):309–325.
  • Adeoye BO, Oyagbemi AA, Asenuga ER, Omobowale TO, Adedapo AA. 2018. The ethanol leaf extract of Andrographis paniculata blunts acute renal failure in cisplatin-induced injury in rats through inhibition of Kim-1 and upregulation of Nrf2 pathway. J Basic Clin Physiol Pharmacol. 30(2):205–217.
  • Adhikari A, Ray M, Sur TK, Roy RK, Das AK. 2018. Experimental evaluation of beneficial potential of Rhizophora mucronata Lam. leaves in Cisplatin-induced nephrotoxic animal model. Int J Biomed Res. 9(2):88–92.
  • Ahmad S, Hussain A, Hussain A, Abdullah I, Ali MS, Froeyen M, Mirza MU. 2019. Quantification of Berberine in Berberis vulgaris L. root extract and its curative and prophylactic role in cisplatin-induced in vivo toxicity and in vitro cytotoxicity. Antioxidants. 8(6):185.
  • Ahmed LA, Shehata NI, Abdelkader NF, Khattab MM. 2014. Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice. PLoS One. 9(10):e108889.
  • Akca G, Eren H, Tumkaya L, Mercantepe T, Horsanali MO, Deveci E, Dil E, Yilmaz A. 2018. The protective effect of astaxanthin against cisplatin-induced nephrotoxicity in rats. Biomed Pharmacother. 100:575–582.
  • Akhtar N, Zaman SU, Khan BA, Amir MN, Ebrahimzadeh MA. 2011. Calendula extract: effects on mechanical parameters of human skin. Acta Pol Pharm. 68:693–701.
  • Aksoy A, Karaoglu A, Akpolat N, Naziroglu M, Ozturk T, Karagoz ZK. 2015. Protective role of selenium and high dose vitamin E against cisplatin - induced nephrotoxicty in rats. Asian Pac J Cancer Prev. 16(16):6877–6882.
  • Albers JW, Chaudhry V, Cavaletti G, Donehower RC. 2014. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev. 16(2):CD005228.
  • Ali BH, Al Moundhri MS. 2006. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol. 44(8):1173–1183.
  • Alibakhshi T, Khodayar MJ, Khorsandi L, Rashno M, Zeidooni L. 2018. Protective effects of zingerone on oxidative stress and inflammation in cisplatin-induced rat nephrotoxicity. Biomed Pharmacother. 105:225–232.
  • Al-Kharusi N, Babiker HA, Al-Salam S, Waly MI, Nemmar A, Al-Lawati I, Yasin J, Beegam S, Ali BH. 2013. Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: a dose-dependent study. Eur Rev Med Pharmacol Sci. 17:299–310.
  • Alvarado CS, Kretschmar C, Joshi VV, Toledano S, Cantor A, Strother D, Nitschke R, Castleberry RP. 1997. Chemotherapy for patients with recurrent or refractory neuroblastoma: a POG Phase II study. J Pediatr Hematol Oncol. 19:62–67.
  • Amirshahrokhi K, Khalili AR. 2015. Thalidomide ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in an experimental model. Inflammation. 38(2):476–484.
  • An Y, Xin H, Yan W, Zhou X. 2011. Amelioration of cisplatin-induced nephrotoxicity by pravastatin in mice. Exp Toxicol Pathol. 63(3):215–219.
  • Andres S, Pevny S, Ziegenhagen R, Bakhiya N, Schäfer B, Hirsch-Ernst KI, Lampen A. 2018. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res. 62(1):1700447.
  • Arjumand W, Seth A, Sultana S. 2011. Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats. Food Chem Toxicol. 49(9):2013–2021.
  • Ashrafi F, Nematbakhsh M, Safari T, Talebi A, Nasri H, Khazaei M, Baradaran-Mahdavi MM, Jafapisheh A, Olia B, Pirhaji O, et al. 2012. A combination of vitamin C and losartan for cisplatin- induced nephrotoxicity in rats. Iran J Kidney Dis. 6(5):361–365.
  • Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A. 2005. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology. 212(2–3):116–123.
  • Badawy AM, El-Naga RN, Gad AM, Tadros MG, Fawzy HM. 2019. Wogonin pre-treatment attenuates cisplatin-induced nephrotoxicity in rats: impact on PPAR-γ, inflammation, apoptosis and Wnt/β-catenin pathway. Chem Biol Interact. 308:137–146.
  • Balm AJM, Rasch CRN, Schornagel JH, Hilgers FJM, Keus RB, Schultze-Kool L, Ackerstaff AH, Busschers W, Tan IB. 2004. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck. 26(6):485–493.
  • Bami E, Ozakpınar OB, Ozdemir-Kumral ZN, Köroglu K, Ercan F, Cirakli Z, Sekerler T, Izzettin FV, Sancar M, Okuyan B. 2017. Protective effect of ferulic acid on cisplatin induced nephrotoxicity in rats. Environ Toxicol Pharmacol. 54:105–111.
  • Baradaran A, Nasri H, Rafieian-Kopaei M. 2015. Protection of renal tubular cells by antioxidants: current knowledge and new trends. Cell J. 16(4):568–571.
  • Batiha GES, Beshbishy AM, Ikram M, Mulla ZS, El-Hack MEA, Taha AE, Algammal AM, Elewa YHA. 2020. The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin. Foods. 9(3):374.
  • Bayomi HS, Elsherbiny NM, El-Gayar AM, Al-Gayyar MMH. 2013. Evaluation of renal protective effects of inhibiting TGF-β type I receptor in a cisplatin-induced nephrotoxicity model. Eur Cytokine Netw. 24(4):139–147.
  • Bazmandegan G, Amirteimoury M, Kaeidi A, Shamsizadeh A, Khademalhosseini M, Nematollahi MH, Hassanipour M, Fatemi I. 2019. Sumatriptan ameliorates renal injury induced by cisplatin in mice. Iran J Basic Med Sci. 22(5):563–567.
  • Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics. 50(4):1088–1101.
  • Behiry S, Rabie A, Kora M, Ismail W, Sabry D, Zahran A. 2018. Effect of combination sildenafil and gemfibrozil on cisplatin-induced nephrotoxicity; role of heme oxygenase-1. Ren Fail. 40(1):371–378.
  • Boroushaki MT, Rajabian A, Farzadnia M, Hoseini A, Poorlashkari M, Taghavi A, Dolati K, Bazmandegan G. 2015. Protective effect of pomegranate seed oil against cisplatin-induced nephrotoxicity in rat. Ren Fail. 37(8):1338–1343.
  • Cao W, Yuan Y, Liu X, Li Q, An X, Huang Z, Wu L, Zhang B, Zhang A, Xing C. 2019. Adenosine kinase inhibition protects against cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol. 317(1):F107–F115.
  • Carvalho Rodrigues MA, Silva Faria MC, da Santos NAG, dos Gobe GC, dos Santos AC. 2013. Carvedilol efficiently protects kidneys without affecting the antitumor efficacy of cisplatin in mice. Chem Biol Interact. 206(1):90–99.
  • Casanova AG, Hernández-Sánchez MT, López-Hernández FJ, Martínez-Salgado C, Prieto M, Vicente-Vicente L, Morales AI. 2020. Systematic review and meta-analysis of the efficacy of clinically tested protectants of cisplatin nephrotoxicity. Eur J Clin Pharmacol. 76(1):23–33.
  • Chen X, Wei W, Li Y, Huang J, Ci X. 2019. Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis. Chem Biol Interact. 308:269–278.
  • Chirino YI, Pedraza-Chaverri J. 2009. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol. 61(3):223–242.
  • Chirino YI, Sánchez-González DJ, Martínez-Martínez CM, Cruz C, Pedraza-Chaverri J. 2008. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology. 245(1–2):18–23.
  • Cowan MM. 1999. Plant products as antimicrobial agents. Clin Microbiol Rev. 12(4):564–582.
  • Cravotto G, Boffa L, Genzini L, Garella D. 2010. Phytotherapeutics: an evaluation of the potential of 1000 plants. J Clin Pharm Ther. 35(1):11–48.
  • Dahal A, Bellows BK, Sonpavde G, Tantravahi SK, Choueiri TK, Galsky MD, Agarwal N. 2016. Incidence of severe nephrotoxicity with cisplatin based on renal function eligibility criteria: indirect comparison meta-analysis. Am J Clin Oncol. 39(5):497–506.
  • Darwish MA, Abo-Youssef AM, Khalaf MM, Abo-Saif AA, Saleh IG, Abdelghany TM. 2018. Resveratrol influences platinum pharmacokinetics: a novel mechanism in protection against cisplatin-induced nephrotoxicity. Toxicol Lett. 290:73–82.
  • Darwish MA, Abo-Youssef AM, Khalaf MM, Abo-Saif AA, Saleh IG, Abdelghany TM. 2017. Vitamin E mitigates cisplatin-induced nephrotoxicity due to reversal of oxidative/nitrosative stress, suppression of inflammation and reduction of total renal platinum accumulation. J Biochem Mol Toxicol. 31(1):1.
  • Dasari S, Tchounwou PB. 2014. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 740:364–378.
  • Dehnamaki F, Karimi A, Pilevarian AA, Fatemi I, Hakimizadeh E, Kaeidi A, Allahtavakoli M, Rahmani MR, Khademalhosseini M, Bazmandegan G. 2019. Treatment with troxerutin protects against cisplatin-induced kidney injury in mice. Acta Chir Belg. 119(1):31–37.
  • Dickey DT, Wu YJ, Muldoon LL, Neuwelt EA. 2005. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther. 314(3):1052–1058.
  • Divya MK, Lincy L, Raghavamenon AC, Babu TD. 2016. Ameliorative effect of Apodytes dimidiata on cisplatin-induced nephrotoxicity in Wistar rats. Pharm Biol. 54(10):2149–2157.
  • Domitrović R, Cvijanović O, Pugel EP, Zagorac GB, Mahmutefendić H, Škoda M. 2013. Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney. Toxicology. 310:115–123.
  • Domitrović R, Cvijanović O, Šušnić V, Katalinić N. 2014. Renoprotective mechanisms of chlorogenic acid in cisplatin-induced kidney injury. Toxicology. 324:98–107.
  • Duan Z, Cai G, Li J, Chen X. 2020. Cisplatin-induced renal toxicity in elderly people. Ther Adv Med Oncol. 12:175883592092343.
  • Egger M, Smith GD, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315(7109):629–634.
  • El-Garhy AM, Abd El-Raouf OM, El-Sayeh BM, Fawzy HM, Abdallah DM. 2014. Ellagic acid antiinflammatory and antiapoptotic potential mediate renoprotection in cisplatin nephrotoxic rats: ellagic acid reduces cisplatin nephrotoxicity. J Biochem Mol Toxicol. 28(10):472–479.
  • El-Naga RN. 2014. Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: impact on NOX-1, inflammation and apoptosis. Toxicol Appl Pharmacol. 274(1):87–95.
  • El-Naga RN, Mahran YF. 2016. Indole-3-carbinol protects against cisplatin-induced acute nephrotoxicity: role of calcitonin gene-related peptide and insulin-like growth factor-1. Sci Rep. 6:29857.
  • El-Sayed ESM, Abd El-Raouf OM, Fawzy HM, Manie MF. 2013. Comparative study of the possible protective effects of cinnamic acid and cinnamaldehyde on cisplatin-induced nephrotoxicity in rats: cinnamon prevents nephrotoxicity. J Biochem Mol Toxicol. 27(12):508–514.
  • Elsherbiny NM, Eladl MA, Al-Gayyar MMH. 2016. Renal protective effects of arjunolic acid in a cisplatin-induced nephrotoxicity model. Cytokine. 77:26–34.
  • Erman F, Tuzcu M, Orhan C, Sahin N, Sahin K. 2014. Effect of lycopene against cisplatin-induced acute renal injury in rats: organic anion and cation transporters evaluation. Biol Trace Elem Res. 158(1):90–95.
  • Farooqui Z, Ahmed F, Rizwan S, Shahid F, Khan AA, Khan F. 2017. Protective effect of Nigella sativa oil on cisplatin induced nephrotoxicity and oxidative damage in rat kidney. Biomed Pharmacother. 85:7–15.
  • Fatima S, Al-Mohaimeed N, Al-Shaikh Y, Tyagi P, Banu N, Hasan S, Arjumand S. 2016. Combined treatment of epigallocatechin gallate and Coenzyme Q10 attenuates cisplatin-induced nephrotoxicity via suppression of oxidative/nitrosative stress, inflammation and cellular damage. Food Chem Toxicol. 94:213–220.
  • Fernández-Rojas B, Medina-Campos ON, Hernández-Pando R, Negrette-Guzmán M, Huerta-Yepez S, Pedraza-Chaverri J. 2014. C-Phycocyanin prevents cisplatin-induced nephrotoxicity through inhibition of oxidative stress. Food Funct. 5(3):480–490.
  • Fouad A, Al-Melhim W. 2018. Vanillin mitigates the adverse impact of cisplatin and methotrexate on rat kidneys. Hum Exp Toxicol. 37(9):937–943.
  • Gad AM, El-Raouf OMA, El-Sayeh BM, Fawzy HM, Abdallah DM. 2017. Renoprotective effects of montelukast in an experimental model of cisplatin nephrotoxicity in rats. J Biochem Mol Toxicol. 31(12):e21979.
  • Galgamuwa R, Hardy K, Dahlstrom JE, Blackburn AC, Wium E, Rooke M, Cappello JY, Tummala P, Patel HR, Chuah A, et al. 2016. Dichloroacetate prevents cisplatin-induced nephrotoxicity without compromising cisplatin anticancer properties. J Am Soc Nephrol. 27(11):3331–3344.
  • García Sar D, Montes-Bayón M, Blanco González E, Sierra Zapico LM, Sanz-Medel A. 2011. Reduction of cisplatin-induced nephrotoxicity in vivo by selenomethionine: the effect on cisplatin-DNA adducts. Chem Res Toxicol. 24(6):896–904.
  • Givol O, Kornhaber R, Visentin D, Cleary M, Haik J, Harats M. 2019. A systematic review of Calendula officinalis extract for wound healing. Wound Repair Regen. 27(5):548–561.
  • Gómez-Sierra T, Eugenio-Pérez D, Sánchez-Chinchillas A, Pedraza-Chaverri J. 2018. Role of food-derived antioxidants against cisplatin induced-nephrotoxicity. Food Chem Toxicol. 120:230–242.
  • Gómez-Sierra T, Molina-Jijón E, Tapia E, Hernández-Pando R, García-Niño WR, Maldonado PD, Reyes JL, Barrera-Oviedo D, Torres I, Pedraza-Chaverri J. 2014. S-allylcysteine prevents cisplatin-induced nephrotoxicity and oxidative stress: SAC prevents cisplatin-induced renal damage. J Pharm Pharmacol. 66(9):1271–1281.
  • Goyal Y, Koul A, Ranawat P. 2019. Ellagic acid ameliorates cisplatin toxicity in chemically induced colon carcinogenesis. Mol Cell Biochem. 453(1–2):205–215.
  • Hagar H, Medany AE, Salam R, Medany GE, Nayal OA. 2015. Betaine supplementation mitigates cisplatin-induced nephrotoxicity by abrogation of oxidative/nitrosative stress and suppression of inflammation and apoptosis in rats. Exp Toxicol Pathol. 67(2):133–141.
  • Han MS, Han IH, Lee D, An JM, Kim SN, Shin MS, Yamabe N, Hwang GS, Yoo HH, Choi SJ, et al. 2016. Beneficial effects of fermented black ginseng and its ginsenoside 20(S)-Rg3 against cisplatin-induced nephrotoxicity in LLC-PK1 cells. J Ginseng Res. 40(2):135–140.
  • Hassan HA, Edrees GM, El-Gamel EM, El-Sayed EA. 2014. Amelioration of cisplatin-induced nephrotoxicity by grape seed extract and fish oil is mediated by lowering oxidative stress and DNA damage. Cytotechnology. 66(3):419–429.
  • Hayati F, Hossainzadeh M, Shayanpour S, Abedi-Gheshlaghi Z, Beladi Mousavi SS. 2016. Prevention of cisplatin nephrotoxicity. J Nephropharmacol. 5(1):57–60.
  • He L, Zhang Y, Kang N, Wang Y, Zhang Z, Zha Z, Yang S, Xu Q, Liu Y. 2019. Anemoside B4 attenuates nephrotoxicity of cisplatin without reducing anti-tumor activity of cisplatin. Phytomedicine. 56:136–146.
  • Helmy MM, Helmy MW, Abd Allah DM, Abo Zaid AM, Mohy El-Din MM. 2014. Selective ET(A) receptor blockade protects against cisplatin-induced acute renal failure in male rats . Eur J Pharmacol. 730:133–139.
  • Hirosawa A, Niitani H, Hayashibara K, Tsuboi E. 1989. Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine. Cancer Chemother Pharmacol. 23(4):255–258.
  • Holst B, Williamson G. 2008. Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants. Curr Opin Biotechnol. 19(2):73–82.
  • Hosseini A, Fanoudi S, Mollazadeh H, Aghaei A, Boroushaki M. 2018. Protective effect of Rheum turkestanicum against cisplatin by reducing oxidative stress in kidney tissue. J Pharm Bioallied Sci. 10(2):66–71.
  • Huang H, Shen Z, Geng Q, Wu Z, Shi P, Miao X. 2017. Protective effect of Schisandra chinensis bee pollen extract on liver and kidney injury induced by cisplatin in rats. Biomed Pharmacother. 95:1765–1776.
  • Huang YC, Tsai MS, Hsieh PC, Shih JH, Wang TS, Wang YC, Lin TH, Wang SH. 2017. Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling. Toxicol Appl Pharmacol. 329:128–139.
  • Huang D, Wang C, Duan Y, Meng Q, Liu Z, Huo X, Sun H, Ma X, Liu K. 2017. Targeting Oct2 and P53: formononetin prevents cisplatin-induced acute kidney injury. Toxicol Appl Pharmacol. 326:15–24.
  • Huang S, You J, Wang K, Li Y, Zhang Y, Wei H, Liang X, Liu Y. 2019. N-acetylcysteine attenuates cisplatin-induced acute kidney injury by inhibiting the C5a receptor. Biomed Res Int. 2019:4805853.
  • Jesse CR, Bortolatto CF, Wilhelm EA, Roman SS, Prigol M, Nogueira CW. 2014. The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice: pioglitazone protects against cisplatin-induced renal damage in mice. J Appl Toxicol. 34(1):25–32.
  • Jia Z, Wang N, Aoyagi T, Wang H, Liu H, Yang T. 2011. Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis. Kidney Int. 79(1):77–88.
  • Jing T, Liao J, Shen K, Chen X, Xu Z, Tian W, Wang Y, Jin B, Pan H. 2019. Protective effect of urolithin a on cisplatin-induced nephrotoxicity in mice via modulation of inflammation and oxidative stress. Food Chem Toxicol. 129:108–114.
  • Kandemir FM, Yildirim S, Caglayan C, Kucukler S, Eser G. 2019. Protective effects of zingerone on cisplatin-induced nephrotoxicity in female rats. Environ Sci Pollut Res Int. 26(22):22562–22574.
  • Kang L, Zhao H, Chen C, Zhang X, Xu M, Duan H. 2016. Sappanone A protects mice against cisplatin-induced kidney injury. Int Immunopharmacol. 38:246–251.
  • Karakoc HTE, Altintas R, Parlakpinar H, Polat A, Samdanci E, Sagir M, Duran ZR. 2015. Protective effects of molsidomine against cisplatin-induced nephrotoxicity. Adv Clin Exp Med. 24(4):585–593.
  • KDIGO. 2012. Section 2: AKI definition. Kidney Int Suppl. 2:19–36.
  • Kenza B, Djihane A, Mouad B, Ratiba M, Samir B, Fadila B, Souad A. 2017. Renoprotective effect of Centaurea choulettiana Pomel (Asteraceae) leaves on cisplatin-induced oxidative stress and renal dysfunction in mice. J App Pharm Sci. 7(11):147–154.
  • Khairnar SI, Mahajan UB, Patil KR, Patel HM, Shinde SD, Goyal SN, Belemkar S, Ojha S, Patil CR. 2020. Disulfiram and its copper chelate attenuate cisplatin-induced acute nephrotoxicity in rats via reduction of oxidative stress and inflammation. Biol Trace Elem Res. 193(1):174–184.
  • Kidera Y, Kawakami H, Sakiyama T, Okamoto K, Tanaka K, Takeda M, Kaneda H, Nishina S, Tsurutani J, Fujiwara K, et al. 2014. Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection. PLoS One. 9(7):e101902.
  • Kim JS, Kim KS, Son JY, Kim HR, Park JH, Lee SH, Lee DE, Kim IS, Lee KY, Lee BM, et al. 2019. Protective effects of Dendropanax morbifera against cisplatin-induced nephrotoxicity without altering chemotherapeutic efficacy. Antioxidants. 8:256.
  • Kim JY, Park JH, Kim K, Jo J, Leem J, Park KK. 2018. Pharmacological inhibition of caspase-1 ameliorates cisplatin-induced nephrotoxicity through suppression of apoptosis, oxidative stress, and inflammation in mice. Mediators Inflamm. 2018:6571676.
  • Kimoto Y, Nishinohara M, Sugiyama A, Haruna A, Takeuchi T. 2013. Protective effect of lactoferrin on cisplatin-induced nephrotoxicity in rats. J Vet Med Sci. 75(2):159–164.
  • Kintzel PE. 2001. Anticancer drug-induced kidney disorders. Drug Saf. 24(1):19–38.
  • Ko JW, Shin NR, Jung TY, Shin IS, Moon C, Kim SH, Lee IC, Kim SH, Yun WK, Kim HC, et al. 2019. Melatonin attenuates cisplatin-induced acute kidney injury in rats via induction of anti-aging protein, Klotho. Food Chem Toxicol. 129:201–210.
  • Kpemissi M, Eklu-Gadegbeku K, Veerapur VP, Negru M, Taulescu M, Chandramohan V, Hiriyan J, Banakar SM, Nv T, Suhas DS, et al. 2019. Nephroprotective activity of Combretum micranthum G. Don in cisplatin induced nephrotoxicity in rats: in-vitro, in-vivo and in-silico experiments. Biomed Pharmacother. 116:108961.
  • Kumar P, Barua CC, Sulakhiya K, Sharma RK. 2017. Curcumin ameliorates cisplatin-induced nephrotoxicity and potentiates its anticancer activity in SD Rats: potential role of curcumin in breast cancer chemotherapy. Front Pharmacol. 8:132.
  • Li YZ, Ren S, Yan XT, Li HP, Li W, Zheng B, Wang Z, Liu YY. 2018. Improvement of cisplatin-induced renal dysfunction by Schisandra chinensis stems via anti-inflammation and anti-apoptosis effects. J Ethnopharmacol. 217:228–237.
  • Li F, Yao Y, Huang H, Hao H, Ying M. 2018. Xanthohumol attenuates cisplatin-induced nephrotoxicity through inhibiting NF-κB and activating Nrf2 signaling pathways. Int Immunopharmacol. 61:277–282.
  • Li R, Zhang W, Yan X, Hou J, Wang Z, Ding C, Liu W, Zheng Y, Chen C, Li Y, et al. 2019. Arginyl-fructosyl-glucose, a major maillard reaction product of red ginseng, attenuates cisplatin-induced acute kidney injury by regulating nuclear factor κB and phosphatidylinositol 3-kinase/protein kinase B signaling pathways. J Agric Food Chem 67(20):5754–5763.
  • Liu H, Baliga R. 2003. Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int. 63(5):1687–1696.
  • Liu YH, Li K, Tian HQ. 2020. Renoprotective effects of a new free radical scavenger, XH-003, against cisplatin-induced nephrotoxicity. Oxid Med Cell Longev. 2020:9820168.
  • Liu Y, Webb HK, Fukushima H, Micheli J, Markova S, Olson JL, Kroetz DL. 2012. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling. J Pharmacol Exp Ther. 341(3):725–734.
  • Ma P, Zhang S, Su X, Qiu G, Wu Z. 2015. Protective effects of icariin on cisplatin-induced acute renal injury in mice. Am J Transl Res. 7(10):2105–2114.
  • Mahmoud MF, El Shazly SM. 2013. Pioglitazone protects against cisplatin induced nephrotoxicity in rats and potentiates its anticancer activity against human renal adenocarcinoma cell lines. Food Chem Toxicol. 51:114–122.
  • Makhdoumi P, Abnous K, Mehri S, Etemad L, Imenshahidi M, Karimi G. 2018. Oral deferiprone administration ameliorates cisplatin-induced nephrotoxicity in rats. J Pharm Pharmacol. 70(10):1357–1368.
  • Malik S, Bhatia J, Suchal K, Gamad N, Dinda AK, Gupta YK, Arya DS. 2015. Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects. Exp Toxicol Pathol. 67(7–8):427–433.
  • Malmström H, Rasmussen S, Simonsen E. 1993. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer. Gynecol Oncol. 49(2):166–171.
  • Manohar S, Leung N. 2018. Cisplatin nephrotoxicity: a review of the literature. J Nephrol. 31(1):15–25.
  • Markman M, Cleary S, Lucas WE, Howell SB. 1985. Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity. J Clin Oncol. 3(7):925–931.
  • Megyesi J, Safirstein RL, Price PM. 1998. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest. 101(4):777–782.
  • Meng XM, Li HD, Wu WF, Ming-Kuen Tang P, Ren GL, Gao L, Li XF, Yang Y, Xu T, Ma TT, et al. 2018. Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis. Lab Invest. 98(1):79–94.
  • Mercantepe F, Mercantepe T, Topcu A, Yılmaz A, Tumkaya L. 2018. Protective effects of amifostine, curcumin, and melatonin against cisplatin-induced acute kidney injury. Naunyn-Schmiedeberg’s Arch Pharmacol. 391(9):915–931.
  • Mi X, Hou J, Wang Z, Han Y, Ren S, Hu J, Chen C, Li W. 2018. The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK-mediated PI3K/Akt and p53 signaling pathways. Sci Rep. 8(1):15922.
  • Michel HE, Menze ET. 2019. Tetramethylpyrazine guards against cisplatin-induced nephrotoxicity in rats through inhibiting HMGB1/TLR4/NF-κB and activating Nrf2 and PPAR-γ signaling pathways. Eur J Pharmacol. 857:172422.
  • Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. 2010. Mechanisms of cisplatin nephrotoxicity. Toxins. 2(11):2490–2518.
  • Mohamadi Yarijani Z, Godini A, Madani SH, Najafi H. 2018. Reduction of cisplatin-induced renal and hepatic side effects in rat through antioxidative and anti-inflammatory properties of Malva sylvestris L. extract. Biomed Pharmacother. 106:1767–1774.
  • Mohamed HE, El-Swefy SE, Mohamed RH, Ghanim AMH. 2013. Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats. Exp Toxicol Pathol. 65(1–2):197–203.
  • Morsy MA, Heeba GH. 2016. Nebivolol ameliorates cisplatin-induced nephrotoxicity in rats. Basic Clin Pharmacol Toxicol. 118(6):449–455.
  • Muldoon LL, Wu YJ, Pagel MA, Neuwelt EA. 2015. N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models. J Neurooncol. 121(3):433–440.
  • Mundhe NA, Kumar P, Ahmed S, Jamdade V, Mundhe S, Lahkar M. 2015. Nordihydroguaiaretic acid ameliorates cisplatin induced nephrotoxicity and potentiates its anti-tumor activity in DMBA induced breast cancer in female Sprague-Dawley rats. Int Immunopharmacol. 28(1):634–642.
  • Mundhe N, Kumar P, Arora I, Ahmed S, Lahkar M. 2019. Differential effect of NDGA on cisplatin-induced nephrotoxicity in Spargue-Dawley rats. Immunopharmacol Immunotoxicol. 41(1):68–75.
  • Nagwani S, Tripathi YB. 2010. Amelioration of cisplatin induced nephrotoxicity by PTY: a herbal preparation. Food Chem Toxicol. 48(8–9):2253–2258.
  • Nakagawa T, Kakizoe Y, Iwata Y, Miyasato Y, Mizumoto T, Adachi M, Izumi Y, Kuwabara T, Suenaga N, Narita Y, et al. 2018. Doxycycline attenuates cisplatin-induced acute kidney injury through pleiotropic effects. Am J Physiol Renal Physiol. 315(5):F1347–F1357.
  • Naqshbandi A, Khan MW, Rizwan S, Rehman S, Ur Khan F. 2012. Studies on the protective effect of dietary fish oil on cisplatin induced nephrotoxicity in rats. Food Chem Toxicol. 50(2):265–273.
  • Nasri H. 2012. Acute kidney injury and beyond. J Renal Inj Prev. 1(1):1–2.
  • Nazari Soltan Ahmad S, Rashtchizadeh N, Argani H, Roshangar L, Ghorbani Haghjo A, Sanajou D, Panah F, Ashrafi Jigheh Z, Dastmalchi S, Mesgari-Abbasi M. 2018. Dunnione protects against experimental cisplatin-induced nephrotoxicity by modulating NQO1 and NAD + levels. Free Radic Res. 52(7):808–817.
  • Nazari Soltan Ahmad S, Rashtchizadeh N, Argani H, Roshangar L, Ghorbani Haghjo A, Sanajou D, Panah F, Ashrafi Jigheh Z, Dastmalchi S, Ashkan K-C. 2018. Tangeretin protects renal tubular epithelial cells against experimental cisplatin toxicity. Iran J Basic Med Sci. 22(2):179–186.
  • Neamatallah T, El-Shitany NA, Abbas AT, Ali SS, Eid BG. 2018. Honey protects against cisplatin-induced hepatic and renal toxicity through inhibition of NF-κB-mediated COX-2 expression and the oxidative stress dependent BAX/Bcl-2/caspase-3 apoptotic pathway. Food Funct. 9(7):3743–3754.
  • Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. 2017. The essential medicinal chemistry of curcumin. J Med Chem. 60(5):1620–1637.
  • Oh GS, Kim HJ, Choi JH, Shen A, Choe SK, Karna A, Lee SH, Jo HJ, Yang SH, Kwak TH, Lee CH, Park R, et al. 2014. Pharmacological activation of NQO1 increases NAD + levels and attenuates cisplatin-mediated acute kidney injury in mice. Kidney Int. 85(3):547–560.
  • Oh GS, Kim HJ, Shen A, Lee SB, Khadka D, Pandit A, So HS. 2014. Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies. Electrolyte Blood Press. 12(2):55–65.
  • Ortega-Domínguez B, Aparicio-Trejo OE, García-Arroyo FE, León-Contreras JC, Tapia E, Molina-Jijón E, Hernández-Pando R, Sánchez-Lozada LG, Barrera-Oviedo D, Pedraza-Chaverri J. 2017. Curcumin prevents cisplatin-induced renal alterations in mitochondrial bioenergetics and dynamic. Food Chem Toxicol. 107(A):373–385.
  • Ozkok A, Edelstein CL. 2014. Pathophysiology of cisplatin-induced acute kidney injury. Biomed Res Int. 2014:967826.
  • Pan H, Chen J, Shen K, Wang X, Wang P, Fu G, Meng H, Wang Y, Jin B. 2015. Mitochondrial modulation by epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice. PloS One. 10(4):e0124775.
  • Pan H, Shen K, Wang X, Meng H, Wang C, Jin B. 2014. Protective effect of metalloporphyrins against cisplatin-induced kidney injury in mice. PLoS One. 9(1):e86057.
  • Park CH, Lee AY, Kim JH, Seong SH, Cho EJ, Choi JS, Kim MJ, Yang S, Yokozawa T, Shin YS. 2019. Protective effects of serotonin and its derivatives, N-feruloylserotonin and N-(p-coumaroyl) serotonin, against cisplatin-induced renal damage in mice. Am J Chin Med. 47(2):369–383.
  • Park CH, Lee AY, Kim JH, Seong SH, Jang GY, Cho EJ, Choi JS, Kwon J, Kim YO, Lee SW, et al. 2018. Protective effect of safflower seed on cisplatin-induced renal damage in mice via oxidative stress and apoptosis-mediated pathways. Am J Chin Med. 46(1):157–174.
  • Perez RP. 1998. Cellular and molecular determinants of cisplatin resistance. Eur J Cancer. 34(10):1535–1542.
  • Pérez-Rojas JM, Guerrero-Beltrán CE, Cruz C, Sánchez-González DJ, Martínez-Martínez CM, Pedraza-Chaverri J. 2011. Preventive effect of tert-butylhydroquinone on cisplatin-induced nephrotoxicity in rats. Food Chem Toxicol. 49(10):2631–2637.
  • Potočnjak I, Broznić D, Kindl M, Kropek M, Vladimir-Knežević S, Domitrović R. 2017. Stevia and stevioside protect against cisplatin nephrotoxicity through inhibition of ERK1/2, STAT3, and NF-κB activation. Food Chem Toxicol. 107(A):215–225.
  • Potočnjak I, Škoda M, Pernjak-Pugel E, Peršić MP, Domitrović R. 2016. Oral administration of oleuropein attenuates cisplatin-induced acute renal injury in mice through inhibition of ERK signaling. Mol Nutr Food Res. 60(3):530–541.
  • Prabhu VV, Kannan N, Guruvayoorappan C. 2013. 1,2-Diazole prevents cisplatin-induced nephrotoxicity in experimental rats. Pharmacol Rep. 65(4):980–990.
  • Prasaja Y, Sutandyo N, Andrajati R. 2015. Incidence of cisplatin-induced nephrotoxicity and associated factors among cancer patients in Indonesia. Asian Pac J Cancer Prev. 16(3):1117–1122.
  • Purena R, Seth R, Bhatt R. 2018. Protective role of Emblica officinalis hydro-ethanolic leaf extract in cisplatin induced nephrotoxicity in Rats. Toxicol Rep. 5:270–277.
  • Qi Z, Li Z, Li W, Liu Y, Wang C, Lin H, Liu J, Li P. 2018. Pseudoginsengenin DQ exhibits therapeutic effects in cisplatin-induced acute kidney injury via Sirt1/NF-κB and caspase signaling pathway without compromising its antitumor activity in mice. Molecules. 23(11):3038.
  • Quesada A, O’Valle F, Montoro-Molina S, Gómez-Morales M, Caba-Molina M, González JF, de Gracia MC, Osuna A, Vargas F, Wangensteen R. 2018. 5-aminoisoquinoline improves renal function and fibrosis during recovery phase of cisplatin-induced acute kidney injury in rats. Biosci Rep. 38(2):BSR20171313.
  • Rafieian-Kopaei M, Baradaran A, Rafieian M. 2013. Plants antioxidants: from laboratory to clinic. J Nephropathol. 2(2):152–153.
  • Ramesh G, Reeves WB. 2003. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol. 285:610–618.
  • Ramesh G, Reeves WB. 2005. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol. 289:166–174.
  • Rana MA, Khan RA, Nasiruddin M, Khan AA. 2016. Amelioration of cisplatin-induced nephrotoxicity by ethanolic extract of Bauhinia purpurea: an in vivo study in rats. Saudi J Kidney Dis Transpl. 27(1):41–48.
  • Rjeibi I, Feriani A, Ben Saad A, Sdayria J, Saidi I, Ncib S, Souid S, Allagui MS, Hfaiedh N. 2018. Lycium europaeum extract: a new potential antioxidant source against cisplatin-induced liver and kidney injuries in mice. Oxid Med Cell Longev. 2018:1630751–1630759.
  • Sahin K, Orhan C, Tuzcu M, Muqbil I, Sahin N, Gencoglu H, Guler O, Padhye SB, Sarkar FH, Mohammad RM. 2014. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity. Biol Trace Elem Res. 157(2):156–163.
  • Sahu BD, Kuncha M, Putcha UK, Sistla R. 2013. Effect of metformin against cisplatin induced acute renal injury in rats: a biochemical and histoarchitectural evaluation. Exp Toxicol Pathol. 65(6):933–940.
  • Saif-Elnasr M, Abdel-Aziz N, El-Batal AI. 2019. Ameliorative effect of selenium nanoparticles and fish oil on cisplatin and gamma irradiation-induced nephrotoxicity in male albino rats. Drug Chem Toxicol. 42(1):94–103.
  • Saifi MA, Sangomla S, Khurana A, Godugu C. 2019. Protective effect of nanoceria on cisplatin-induced nephrotoxicity by amelioration of oxidative stress and pro-inflammatory mechanisms. Biol Trace Elem Res. 189(1):145–156.
  • Saito Y, Okamoto K, Kobayashi M, Narumi K, Furugen A, Yamada T, Iseki K. 2017. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration. Life Sci. 189:18–22.
  • Sánchez-González PD, López-Hernández FJ, López-Novoa JM, Morales AI. 2011. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Crit Rev Toxicol. 41(10):803–821.
  • Sanchez-Gonzalez PD, Lopez-Hernandez FJ, Perez-Barriocanal F, Morales AI, Lopez-Novoa JM. 2011. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity. Nephrol Dial Transplant. 26(11):3484–3495.
  • Sancho-Martínez SM, Prieto-García L, Prieto M, Fuentes-Calvo I, López-Novoa JM, Morales AI, Martínez-Salgado C, López-Hernández FJ. 2018. N-acetylcysteine transforms necrosis into apoptosis and affords tailored protection from cisplatin cytotoxicity. Toxicol Appl Pharmacol. 349:83–93.
  • Sancho-Martínez SM, Prieto-García L, Prieto M, López-Novoa JM, López-Hernández FJ. 2012. Subcellular targets of cisplatin cytotoxicity: an integrated view. Pharmacol Ther. 136(1):35–55.
  • Saral S, Dokumacioglu E, Mercantepe T, Atak M, Cinar S, Saral O, Yildiz L, Iskender H, Tumkaya L. 2019. The effect of white tea on serum TNF-α/NF-κB and immunohistochemical parameters in cisplatin-related renal dysfunction in female rats. Biomed Pharmacother. 112:108604.
  • Sen S, Chakraborty R, Kalita P. 2018. Dillenia indica fruit prevents cisplatin-induced kidney injury in experimental rats through modulation of oxidative stress, marker enzyme, and biochemical changes. Nutrire. 43(1):15.
  • Sener MT, Sener E, Tok A, Polat B, Cinar I, Polat H, Akcay F, Suleyman H. 2012. Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine. Pharmacol Rep. 64(3):594–602.
  • Sharifi-Heris Z, Farahani LA, Haghani H, Abdoli-Oskouee S, Hasanpoor-Azghady SB. 2018. Comparison the effects of topical application of olive and calendula ointments on children’s diaper dermatitis: a triple-blind randomized clinical trial . Dermatol Ther. 31(6):e12731.
  • Sharma SK, Goyal N. 2012. Protective effect of Heliotropium eichwaldi against cisplatin-induced nephrotoxicity in mice. J Chin Integr Med. 10(5):555–560.
  • Sharp CN, Doll MA, Megyesi J, Oropilla GB, Beverly LJ, Siskind LJ. 2018. Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease. Am J Physiol Renal Physiol. 315:161–172.
  • Sherif IO. 2015. Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna. Clin Exp Nephrol. 19(4):591–597.
  • Shi HH, Wang CC, Guo Y, Xue CH, Zhang TT, Wang YM. 2019. DHA-PC protects kidneys against cisplatin-induced toxicity and its underlying mechanisms in mice. Food Funct. 10(3):1571–1581.
  • Si B, Am H, Ew N. 1992. The antidotal action of sodium nitrite and sodium thiosulfate against cyanide poisoning. J Clin Pharmacol. 32:368–375.
  • Singh VK, Seed TM. 2019. The efficacy and safety of amifostine for the acute radiation syndrome. Expert Opin Drug Saf. 18(11):1077–1090.
  • Soetikno V, Sari S, Ul Maknun L, Sumbung N, Rahmi D, Pandhita B, Louisa M, Estuningtyas A. 2019. Pre-Treatment with Curcumin Ameliorates Cisplatin-Induced Kidney Damage by Suppressing Kidney Inflammation and Apoptosis in Rats. Drug Res. 69(2):75–82.
  • Steinhubl SR. 2008. Why have antioxidants failed in clinical trials? Am J Cardiol. 101:14–19.
  • Sun CY, Nie J, Zheng ZL, Zhao J, Wu LM, Zhu Y, Su ZQ, Zheng GJ, Feng B. 2019. Renoprotective effect of scutellarin on cisplatin-induced renal injury in mice: impact on inflammation, apoptosis, and autophagy. Biomed Pharmacother. 112:108647.
  • Suurmond R, van Rhee H, Hak T. 2017. Introduction, comparison, and validation of meta-essentials: a free and simple tool for meta-analysis. Res Synth Methods. 8(4):537–553.
  • Talhouk R, Karam C, Fostok S, El-Jouni W, Barbour E. 2007. Anti-inflammatory bioactivities in plant extracts. J Med Food. 10(1):1–10.
  • Tayem Y. 2005. Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule. AJP: Renal Physiology. 290:789–794.
  • Teng ZY, Cheng XL, Cai XT, Yang Y, Sun XY, Xu JD, Lu WG, Chen J, Hu CP, Zhou Q, et al. 2015. Ancient Chinese formula Qiong-Yu-Gao protects against cisplatin-induced nephrotoxicity without reducing anti-tumor activity. Sci Rep. 5:15592.
  • Terada Y, Inoue Keiji Matsumoto T, Ishihara M, Hamada K, Shimamura Y, Ogata K, Inoue Kosuke Taniguchi Y, Horino T, Karashima T, Tamura K, et al. 2013. 5-aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo. PLoS One. 8(12):e80850.
  • Topcu-Tarladacalisir Y, Sapmaz-Metin M, Karaca T. 2016. Curcumin counteracts cisplatin-induced nephrotoxicity by preventing renal tubular cell apoptosis. Ren Fail. 38(10):1741–1748.
  • Tripathi YB, Nagwani S, Mishra P, Jha A, Rai SP. 2012. Protective effect of Pueraria tuberosa DC embedded biscuit on cisplatin-induced nephrotoxicity in mice. J Nat Med. 66(1):109–118.
  • Tristão VR, Pessoa EA, Nakamichi R, Reis LA, Batista MC, Durão Junior MdS, Monte JCM. 2016. Synergistic effect of apoptosis and necroptosis inhibitors in cisplatin-induced nephrotoxicity. Apoptosis. 21(1):51–59.
  • Trujillo J, Molina-Jijón E, Medina-Campos ON, Rodríguez-Muñoz R, Reyes JL, Loredo ML, Barrera-Oviedo D, Pinzón E, Rodríguez-Rangel DS, Pedraza-Chaverri J. 2016. Curcumin prevents cisplatin-induced decrease in the tight and adherens junctions: relation to oxidative stress. Food Funct. 7(1):279–293.
  • Tsogbadrakh B, Ryu H, Ju KD, Lee J, Yun S, Yu KS, Kim HJ, Ahn C, Oh KH. 2019. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway. Biochem Biophys Res Commun. 509(3):680–686.
  • Vasaikar N, Mahajan U, Patil KR, Suchal K, Patil CR, Ojha S, Goyal SN. 2018. D-pinitol attenuates cisplatin-induced nephrotoxicity in rats: impact on pro-inflammatory cytokines. Chem Biol Interact. 290:6–11.
  • Verma PK, Raina R, Sultana M, Singh M, Kumar P. 2016. Total antioxidant and oxidant status of plasma and renal tissue of cisplatin-induced nephrotoxic rats: protection by floral extracts of Calendula officinalis Linn. Renal Failure. 38(1):142–150.
  • Vicente-Vicente L, González-Calle D, Casanova AG, Hernández-Sánchez MT, Prieto M, Rama-Merchán JC, Martín-Moreiras J, Martín-Herrero F, Sánchez PL, López-Hernández FJ, et al. 2019. Quercetin, a promising clinical candidate for the prevention of contrast-induced nephropathy. Int J Mol Sci. 20(19):4961.
  • Visacri MB, Quintanilha JCF, de Sousa VM, Amaral LS, de Ambrósio R, Calonga L, Curi SFBB, de Leme MF, Chone CT, Altemani JMC, et al. 2019. Can acetylcysteine ameliorate cisplatin-induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double-blind, placebo-controlled trial involving patients with head and neck cancer. Cancer Med. 8(5):2020–2030.
  • Volarevic V, Djokovic B, Jankovic MG, Harrell CR, Fellabaum C, Djonov V, Arsenijevic N. 2019. Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. J Biomed Sci. 26(1):25.
  • Wang Z, Li Y, Han X, Sun Y, Zhang L, Liu W, Liu X, Li W, Liu Y. 2018. Kidney protection effect of ginsenoside re and its underlying mechanisms on cisplatin-induced kidney injury. Cell Physiol Biochem. 48(5):2219–2229.
  • Wang Y, Luo X, Pan H, Huang W, Wang X, Wen H, Shen K, Jin B. 2015. Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism. Food Chem Toxicol. 83:251–260.
  • Wang S, Xu Y, Weng Y, Fan X, Bai Y, Zheng X, Lou L, Zhang F. 2018. Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation. Food Chem Toxicol. 114:227–236.
  • Xing J, Hou J, Ma Z, Wang Z, Ren S, Wang Y, Liu W, Chen C, Li W. 2019. Ginsenoside Rb3 provides protective effects against cisplatin‐induced nephrotoxicity via regulation of AMPK‐/mTOR‐mediated autophagy and inhibition of apoptosis in vitro and in vivo. Cell Prolif. 52(4):e12627.
  • Xu DP, Li Y, Meng X, Zhou T, Zhou Y, Zheng J, Zhang JJ, Li HB. 2017. Natural antioxidants in foods and medicinal plants: extraction, assessment and resources. Int J Mol Sci. 18(1):96.
  • Yang YI, Ahn JH, Choi YS, Choi JH. 2015. Brown algae phlorotannins enhance the tumoricidal effect of cisplatin and ameliorate cisplatin nephrotoxicity. Gynecol Oncol. 136(2):355–364.
  • Yang C, Guo Y, Huang T, Zhao J, Huang XJ, Tang H, An N, Pan Q, Xu Y, Liu H. 2018. Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation. Biomed Pharmacother. 107:1354–1362.
  • Yang H, Li W, Wang L, Li W, Sun H, He X, Zhang J. 2017. The protective effects of sika deer antler protein on cisplatin-induced nephrotoxicity. Cell Physiol Biochem. 43(1):395–404.
  • Yang M, Wang R, Sun J, Yu K, Chen B, Xu L, Zhao B, Wang H. 2015. The liver X receptor agonist TO901317 protects mice against cisplatin-induced kidney injury. Exp Biol Med. 240(12):1717–1727.
  • Yu X, Meng X, Xu M, Zhang X, Zhang Y, Ding G, Huang S, Zhang A, Jia Z. 2018. Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function. EBioMedicine. 36:266–280.
  • Zhang L, Gu Y, Li H, Cao H, Liu B, Zhang H, Shao F. 2018. Daphnetin protects against cisplatin-induced nephrotoxicity by inhibiting inflammatory and oxidative response. Int Immunopharmacol. 65:402–407.
  • Zhang W, Hou J, Yan X, Leng J, Li R, Zhang J, Xing J, Chen C, Wang Z, Li W. 2018. Platycodon grandiflorum saponins ameliorate cisplatin-induced acute nephrotoxicity through the NF-κB-mediated inflammation and PI3K/Akt/apoptosis signaling pathways. Nutrients. 10(9):1328.
  • Zhang Y, Yuan F, Cao X, Zhai Z, GangHuang Du X, Wang Y, Zhang J, Huang Y, Zhao J, Hou W. 2014. P2X7 receptor blockade protects against cisplatin-induced nephrotoxicity in mice by decreasing the activities of inflammasome components, oxidative stress and caspase-3. Toxicol Appl Pharmacol. 281:1–10.
  • Zhou L, Wei XH, Pan CS, Yan L, Gu YY, Sun K, Liu YY, Wang CS, Fan JY, Han JY. 2017. QiShenYiQi pills, a compound Chinese medicine, prevented cisplatin induced acute kidney injury via regulating mitochondrial function. Front Physiol. 8:1090.
  • Zirak MR, Rahimian R, Ghazi-Khansari M, Abbasi A, Razmi AE, Mehr S, Mousavizadeh K, Dehpour AR. 2014. Tropisetron attenuates cisplatin-induced nephrotoxicity in mice. Eur J Pharmacol. 738:222–229.
  • Zou P, Song J, Jiang B, Pei F, Chen B, Yang X, Liu G, Hu Z. 2014. Epigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse. Int J Clin Exp Pathol. 7(8):4607–4616.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.